Hyperhomocysteinaemia and human reproduction

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 8, 2001, Pages 758-763

  Nelen, W L D M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Homocysteine; MTHFR; Pregnancy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; CYTOSINE; FOLIC ACID; HOMOCYSTEINE; THYMINE;

AMINO ACID METABOLISM; ARTICLE; BIRTH DEFECT; CHROMOSOME ABERRATION; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; NEURAL TUBE DEFECT; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

ABNORMALITIES; ABORTION, SPONTANEOUS; CHROMOSOME ABERRATIONS; FAMILY HEALTH; FEMALE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MODELS, BIOLOGICAL; MUTATION; ODDS RATIO; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 0034831338     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.126     Document Type: Article

References (58)

1. The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: Effect of CBS genotype on biochemical and clinical phenotype and on response to treatment
2. Pregnancy and homocystinuria
3. Pregnancy and homocystinuria
4. The natural history of homocystinuria due to cystathionine β-synthase deficiency
5. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
6. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
7. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies
8. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
9. Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications
10. Homocysteine and human reproduction
11. Homocysteine - A pathophysiological cornerstone in obstetrical and gynaecological disorders?
12. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine study
13. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
14. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
15. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
16. The meiotic stage of nondisjunction in trisomy 21: Determination by using DNA polymorphisms
17. Impaired chromosome segregation in plant anaphase after moderate hypomethylation of DNA
18. DNA methylation and genetic instability in colorectal cancer cells
19. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome
20. Neural-tube defects and derangement of homocysteine metabolism
21. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
22. Homocysteine metabolism in pregnancies complicated by neural-tube defects
23. Altered folate and vitamin B12 metabolism in families with spina bifida offspring
24. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review
25. Nonsyndromic orofacial clefts: Association with maternal hyperhomocysteinemia
26. C677T variant form at the MTHFR gene and CL/P: A risk factor for mothers?
27. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts
28. Congenital heart defects and maternal derangement of homocysteine metabolism
29. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae
30. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis
31. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss
32. A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages
33. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion
34. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss
35. Genetic risk factor for unexplained recurrent early pregnancy loss
36. Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss
37. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss
38. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss
39. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss
40. Hyperhomocysteinemia: A risk factor for placental abruption or infarction
41. Hyperhomocysteinemia - A risk factor for abruptio placentae
42. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: A systematic review
43. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy
44. Increased frequency of genetic thrombophilia in women with complications of pregnancy
45. Underlying disorders associated with severe early-onset preeclampsia
46. Elevated homocyst(e)ine levels with preeclampsia
47. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
48. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome
49. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria
50. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia
51. The metabolic basis of inherited disease
52. Vitamin requirements for the treatment of hyperhomocysteinemia in humans
53. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study
54. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
55. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
56. Folate affects apoptosis in human trophoblastic cells
57. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos
58. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss